SRF’s Q2FY24 print for its chemical business (EBIT down 32.8% YoY) was below our expectations – hurt by lower sales in ref-gas and weakness in specialty sales from destocking. Despite this, SRF expects some growth in specialty chemicals revenue for FY24 and anticipates revival in ref-gas revenue in H2FY24E, as it has started to contract volumes in US for CY24 HFC quota.